Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 2/20 | 0.46 |
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.42 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.41 |
| ▸ | CDK1 | P06493 | 1/20 | 0.41 |
| ▸ | CDK4 | P11802 | 1/20 | 0.41 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.41 |
| ▸ | CCND1 | P24385 | 1/20 | 0.41 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 3/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 6/20 | 0.36 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30799215 | 1.00 | XDH (0.46) | XDHKIF11GABBR2GABBR1ALDH1A1 | |
| SCHEMBL21402590 | 0.86 | KIF11 (0.56) | XDHKIF11GABBR2GABBR1ALDH1A1 | |
| SCHEMBL67628 | 0.81 | KIF11 (0.58) | KIF11ALDH1A1KDM4EAPPAR | |
| SCHEMBL10299815 | 0.81 | KIF11 (0.58) | KIF11ALDH1A1KDM4EAPPAR | |
| SCHEMBL18420270 | 0.81 | NPFFR1 (0.48) | XDHGABBR2GABBR1ALDH1A1KDM4E | |
| SCHEMBL18420271 | 0.81 | NPFFR1 (0.48) | XDHGABBR2GABBR1ALDH1A1KDM4E | |
| SCHEMBL2126131 | 0.79 | NFE2L2 (0.53) | XDHGABBR2GABBR1ALDH1A1KDM4E | |
| SCHEMBL11045503 | 0.79 | NFE2L2 (0.53) | XDHGABBR2GABBR1ALDH1A1KDM4E | |
| SCHEMBL30569765 | 0.79 | NFE2L2 (0.53) | XDHGABBR2GABBR1ALDH1A1KDM4E | |
| SCHEMBL18002827 | 0.78 | KIF11 (0.47) | KIF11ALDH1A1APPSLC22A12NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117603014-A | Meta-diamide compounds for controlling invertebrate pests | FMC公司 | 2024-02-27 | — | — | CN | disclosed |
| EP-4183766-A1 | INTERMEDIATES FOR THE PREPARATION OF META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | FMC Corporation (US) | 2023-05-24 | — | — | EP | disclosed |
| EP-3887354-B1 | META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | FMC CORP (US) | 2023-01-04 | — | — | EP | disclosed |
| US-20210400977-A1 | META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | FMC CORPORATION | 2021-12-30 | — | — | US | disclosed |
| EP-3887354-A1 | META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | FMC Corporation (US) | 2021-10-06 | — | — | EP | disclosed |
| CN-113454065-A | Metadiamide compounds for controlling invertebrate pests | FMC公司 | 2021-09-28 | — | — | CN | disclosed |
| WO-2020112390-A1 | META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | FMC CORPORATION (US) | 2020-06-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210400977-A1 | META-DIAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | DDT, RDX, ACHE | XDH 808/4885KIF11 3642/4885GABBR2 3968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.